🧠AI AnalysisFDA Approves First Targeted Therapy for Primary Membranous Nephropathy
The FDA has approved obinutuzumab for primary membranous nephropathy, marking the first time a dedicated drug has been authorized for this rare autoimmune kidney conditio…